Each of the activities of signal recognition particle (SRP) is contained within a distinct domain: analysis of biochemical mutants of SRP. Siegel V, Walter P (1988) Cell 52: 39-49 Characterization of human microsomal cytochrome P-450 enzymes. Guengerich FP (1989) Annu Rev Pharmacol Toxicol 29: 241-64 p53 has a direct apoptogenic role at the mitochondria. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM (2003) Mol Cell 11: 577-90 Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins. Callejas NA, Boscá L, Williams CS, DuBOIS RN, Martín-Sanz P (2000) Gastroenterology 119: 493-501 Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. DuBois RN, Awad J, Morrow J, Roberts LJ, Bishop PR (1994) J Clin Invest 93: 493-8 Elongation arrest is not a prerequisite for secretory protein translocation across the microsomal membrane. Siegel V, Walter P (1985) J Cell Biol 100: 1913-21 Regulation of the induction of a cytochrome P-450 prostaglandin omega-hydroxylase by pregnancy in rabbit lung. Muerhoff AS, Williams DE, Leithauser MT, Jackson VE, Waterman MR, Masters BS (1987) Proc Natl Acad Sci U S A 84: 7911-4 Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Holla VR, Adas F, Imig JD, Zhao X, Price E, Olsen N, Kovacs WJ, Magnuson MA, Keeney DS, Breyer MD, Falck JR, Waterman MR, Capdevila JH (2001) Proc Natl Acad Sci U S A 98: 5211-6 Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ (1992) Proc Natl Acad Sci U S A 89: 10721-5 Simultaneous transfection of COS-1 cells with mitochondrial and microsomal steroid hydroxylases: incorporation of a steroidogenic pathway into nonsteroidogenic cells. Zuber MX, Mason JI, Simpson ER, Waterman MR (1988) Proc Natl Acad Sci U S A 85: 699-703 Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Shimada T, Guengerich FP (1989) Proc Natl Acad Sci U S A 86: 462-5 Induction of renal arachidonate cytochrome P-450 epoxygenase after uninephrectomy: counterregulation of hyperfiltration. Takahashi K, Harris RC, Capdevila JH, Karara A, Makita K, Jacobson HR, Munger KA, Badr KF (1993) J Am Soc Nephrol 3: 1496-500 Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Shimada T, Iwasaki M, Martin MV, Guengerich FP (1989) Cancer Res 49: 3218-28 Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Shimada T, Martin MV, Pruess-Schwartz D, Marnett LJ, Guengerich FP (1989) Cancer Res 49: 6304-12 Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR (1996) Cancer Res 56: 2979-84 A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Chun YJ, Kim S, Kim D, Lee SK, Guengerich FP (2001) Cancer Res 61: 8164-70 Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by cytochrome P-450 enzymes in human and rat liver microsomes. Shimada T, Guengerich FP (1990) Cancer Res 50: 2036-43 Comparative metabolism of 1-, 2-, and 4-nitropyrene by human hepatic and pulmonary microsomes. Chae YH, Thomas T, Guengerich FP, Fu PP, El-Bayoumy K (1999) Cancer Res 59: 1473-80 Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. Shimada T, El-Bayoumy K, Upadhyaya P, Sutter TR, Guengerich FP, Yamazaki H (1997) Cancer Res 57: 4757-64 Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene. Yun CH, Shimada T, Guengerich FP (1992) Cancer Res 52: 1868-74 Activation of amino-alpha-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Shimada T, Guengerich FP (1991) Cancer Res 51: 5284-91 Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes. Guengerich FP, Shimada T, Yun CH, Yamazaki H, Raney KD, Thier R, Coles B, Harris TM (1994) Environ Health Perspect 102 Suppl 9: 49-53 Sulfenylation of Human Liver and Kidney Microsomal Cytochromes P450 and Other Drug-Metabolizing Enzymes as a Response to Redox Alteration. Albertolle ME, Phan TTN, Pozzi A, Guengerich FP (2018) Mol Cell Proteomics 17: 889-900 HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization. Sivakumaran V, Stanley BA, Tocchetti CG, Ballin JD, Caceres V, Zhou L, Keceli G, Rainer PP, Lee DI, Huke S, Ziolo MT, Kranias EG, Toscano JP, Wilson GM, O'Rourke B, Kass DA, Mahaney JE, Paolocci N (2013) Antioxid Redox Signal 19: 1185-97 Progesterone 16 alpha-hydroxylase activity is catalyzed by human cytochrome P450 17 alpha-hydroxylase. Swart P, Swart AC, Waterman MR, Estabrook RW, Mason JI (1993) J Clin Endocrinol Metab 77: 98-102 Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis. Kapoor M, Kojima F, Qian M, Yang L, Crofford LJ (2006) FASEB J 20: 2387-9 Contributions of human liver cytochrome P450 enzymes to the N-oxidation of 4,4'-methylene-bis(2-chloroaniline). Yun CH, Shimada T, Guengerich FP (1992) Carcinogenesis 13: 217-22 Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays. Shimada T, Gillam EM, Sandhu P, Guo Z, Tukey RH, Guengerich FP (1994) Carcinogenesis 15: 2523-9 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5. Huang Z, Guengerich FP, Kaminsky LS (1998) Carcinogenesis 19: 867-72 In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Guengerich FP, Kim DH (1990) Carcinogenesis 11: 2275-9 Metabolic activation of aromatic amines by human pancreas. Anderson KE, Hammons GJ, Kadlubar FF, Potter JD, Kaderlik KR, Ilett KF, Minchin RF, Teitel CH, Chou HC, Martin MV, Guengerich FP, Barone GW, Lang NP, Peterson LA (1997) Carcinogenesis 18: 1085-92 Microsomal cytochrome P450 and eicosanoid metabolism. Capdevila JH, Harris RC, Falck JR (2002) Cell Mol Life Sci 59: 780-9 Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor. Lavieri RR, Scott SA, Selvy PE, Kim K, Jadhav S, Morrison RD, Daniels JS, Brown HA, Lindsley CW (2010) J Med Chem 53: 6706-19 Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM). Morris LC, Nance KD, Gentry PR, Days EL, Weaver CD, Niswender CM, Thompson AD, Jones CK, Locuson CW, Morrison RD, Daniels JS, Niswender KD, Lindsley CW (2014) J Med Chem 57: 10192-7 Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu₅). Turlington M, Malosh C, Jacobs J, Manka JT, Noetzel MJ, Vinson PN, Jadhav S, Herman EJ, Lavreysen H, Mackie C, Bartolomé-Nebreda JM, Conde-Ceide S, Martín-Martín ML, Tong HM, López S, MacDonald GJ, Steckler T, Daniels JS, Weaver CD, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Stauffer SR (2014) J Med Chem 57: 5620-37 Discovery, synthesis, and structure-activity relationship development of a series of N-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu(4)) with oral efficacy in an antiparkinsonian animal model. Jones CK, Engers DW, Thompson AD, Field JR, Blobaum AL, Lindsley SR, Zhou Y, Gogliotti RD, Jadhav S, Zamorano R, Bogenpohl J, Smith Y, Morrison R, Daniels JS, Weaver CD, Conn PJ, Lindsley CW, Niswender CM, Hopkins CR (2011) J Med Chem 54: 7639-47
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.